From each FDA label

Do GLP-1s cause insomnia?

We found no sentence on insomnia in the parts of the current GLP-1 labels we read. Saxenda's label does list insomnia, in its table of adverse reactions, rather than in a sentence.

Not from trials

Reports to FDA about insomnia

Counts of voluntary reports from patients and doctors. They cannot show that a medicine caused anything and cannot give a rate, and a brand used by more people draws more reports.

MedicineReports namingAll reports on it
OzempicInsomnia: 81070,863
MounjaroInsomnia: 62797,440
ZepboundInsomnia: 57580,835
ByettaInsomnia: 48852,087
TrulicityInsomnia: 45987,279
VictozaInsomnia: 42041,462
WegovyInsomnia: 27325,993
Rybelsus and Ozempic tabletsInsomnia: 907,758
SaxendaInsomnia: 737,270
FoundayoInsomnia: 243,050

Counted through openFDA from FDA's Adverse Event Reporting System, refreshed weekly. One report can name several terms.

Updated automatically

Latest FDA label updates

Written from each source's own record as it changes. Every change on GLPcompare

Other side effects

Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.